title: The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulin.
abstract: Diabetic retinopathy is the leading cause of blindness in working age persons. Targeted studies have uncovered several components of the pathophysiology of the disease without unveiling the basic mechanisms. This study describes the use of complementary proteomic and genomic discovery methods that revealed that the proteins of the crystallin superfamily are increased dramatically in early diabetic retinopathy. Orthogonal methods confirmed that the amplitude of the up-regulation is greater than other changes described so far in diabetic retinopathy. A detailed time course study during diabetes showed differential up-regulation of the different isoforms of the crystallins superfamily. alpha- and beta-crystallins were regulated primarily at the translation level, whereas gamma-crystallins were also regulated transcriptionally. We also demonstrated cell-specific patterns of expression of the different crystallins in normal and diabetic rat retinas. In addition, systemic and periocular insulin treatments restored retinal crystallin protein expression during diabetes, indicating effects of phosphoinositide 3-kinase/Akt activity. Altogether this work shows the importance of proteomics discovery methods coupled with targeted approaches to unveil new disease mechanistic details and therapeutic targets.
authors.affiliation: Department of Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania 17033, USA.
authors.forename: Patrice E
authors.initials: PE
authors.lastname: Fort
authors.forename: Willard M
authors.initials: WM
authors.lastname: Freeman
authors.forename: Mandy K
authors.initials: MK
authors.lastname: Losiewicz
authors.forename: Ravi S J
authors.initials: RS
authors.lastname: Singh
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Gardner
mesh_terms: D000818:Animals; D015153:Blotting, Western; D003459:Crystallins / Q000235:genetics / Q000378:metabolism*; D003930:Diabetic Retinopathy / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism*; D004333:Drug Administration Routes; D015180:Electrophoresis, Gel, Two-Dimensional; D007328:Insulin / Q000008:administration & dosage* / Q000494:pharmacology*; D007553:Isotope Labeling; D020411:Oligonucleotide Array Sequence Analysis; D021381:Protein Transport / Q000187:drug effects; D020543:Proteome / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D015203:Reproducibility of Results; D012160:Retina / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors; D015854:Up-Regulation / Q000187:drug effects*
chemical_list: D003459:Crystallins; D007328:Insulin; D020543:Proteome; D012333:RNA, Messenger